PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Pipeline portfolio

Phase III pipeline portfolio: Global CNS disorders

therapeutics market

Phase II pipeline portfolio: Global CNS disorders

therapeutics market

Phase I pipeline portfolio: Global CNS disorders

therapeutics market

Pre-clinical and discovery pipeline portfolio: Global CNS

disorders therapeutics market

PART 06: Market landscape

Market overview

Five forces analysis

PART 07: Market segmentation by type of disease

Global depression drugs market

Global MS drugs market

Global schizophrenia drugs market

Global bipolar disorder therapeutics market

Global AD drugs market

Global epilepsy drugs market

Global PD drugs market

PART 08: Geographical segmentation

CNS disorders therapeutics market in Americas

CNS disorders therapeutics market in EMEA

CNS disorders therapeutics market in APAC

PART 09: Market drivers

Special regulatory designations for CNS disorders

New DMD approvals for AD, PD, and MS

Development of novel therapeutics using innovative

technologies

High growth potential of mAbs

PART 10: Impact of drivers

PART 11: Market challenges

High failure rates of late-stage products in clinical trials

Growing use of non-invasive neuromodulation and

seizure management devices

Unavailability of standard diagnostic methods

Increase in rehabilitation programs

Social stigma associated with CNS diseases

PART 12: Impact of drivers and challenges

PART 13: Market trends

Popularity of me-too drugs

Increased uptake of new-generation drugs

Reformulation of marketed drugs

Focus on regenerative therapies for CNS disorders

Increase in use of LAI antipsychotics

PART 14: Vendor landscape

Competitive scenario

GlaxoSmithKline

Pfizer

Eli Lilly

Janssen Pharmaceuticals

Novartis

Other prominent vendors

PART 15: Appendix

List of abbreviations

PART 16: Explore Technavio